Jurnal Respirasi

Universitas Airlangga

Journal websitePeer review: Double-blind review
Evaluation status available after sign-in

About the journal

Jurnal Respirasi is an open-access journal published by Universitas Airlangga in Indonesia, publishing in english. It is listed in DOAJ according to the sources read. Declared publication charge: 100 USD. Declared review time at DOAJ: 10 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
Universitas Airlangga
ISSN
2407-0831 · 2621-8372
Country
Indonesia
Languages
english
Access
Open access
Declared publication charge
100 USD
Articles in DOAJ
281
Declared review time
10 weeks
Declared peer-review model
double_blind

Index listings

  • DOAJ · 2022-01-03
Indexing
DOAJ
APC
100 USD
Declared review time (DOAJ)
10 weeks — journal-declared only (not measured)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Articles in DOAJ

281

Most recent article

3 months ago

Average review time (journal-declared via DOAJ)

10weeks

Works in OpenAlex

269

Last recorded publication year

2025

Reported by OpenAlex in 1 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

10

i10-index

10

From OpenAlex open data (CC0).

Editorial & policy12
Last DOAJ review date
2022-02-23
Added to DOAJ
2022-01-03
Declared plagiarism screening
Declared
Other fees beyond APC
No
Declared digital preservation
PKP PN
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
CLOCKSSPKP PN
Editorial board
Official page ↗
Open references deposited at Crossref
63%
ORCID iDs in current deposits
100%
Enrolled in Crossref Similarity Check
✓
Deposits licence metadata at Crossref
✓
APC waiver policy
View policy
Peer-review policy
View policy
Identity & continuity2
Alternate titles
Journal of RespirologyJR
Source type
journal
Classification2

Subjects (DOAJ)

Medicine

LCC codes

R

Subject areas

  • Tuberculosis Research and Epidemiology
  • Tuberculosis Research and Epidemiology
  • Public Health and Nutrition
  • Public Health and Nutrition
  • Pleural and Pulmonary Diseases
  • Pleural and Pulmonary Diseases
  • Chronic Obstructive Pulmonary Disease (COPD) Research
  • Chronic Obstructive Pulmonary Disease (COPD) Research
Show all subjects (50)
  • Diagnosis and treatment of tuberculosis
  • Diagnosis and treatment of tuberculosis
  • Lung Cancer Diagnosis and Treatment
  • Lung Cancer Diagnosis and Treatment
  • Tracheal and airway disorders
  • Tracheal and airway disorders
  • Lung Cancer Treatments and Mutations
  • Lung Cancer Treatments and Mutations
  • Infectious Diseases and Tuberculosis
  • Infectious Diseases and Tuberculosis
  • Asthma and respiratory diseases
  • COVID-19 Clinical Research Studies
  • Asthma and respiratory diseases
  • Respiratory Support and Mechanisms
  • COVID-19 Clinical Research Studies
  • Respiratory Support and Mechanisms
  • Healthcare Quality and Satisfaction
  • COVID-19 Prevention and Impact
  • COVID-19 Prevention and Impact
  • Healthcare Quality and Satisfaction
  • Occupational and environmental lung diseases
  • Occupational and environmental lung diseases
  • Pediatric health and respiratory diseases
  • Pediatric health and respiratory diseases
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Pneumonia and Respiratory Infections
  • Methodologies in Health Research and Practice
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Pneumonia and Respiratory Infections
  • Methodologies in Health Research and Practice
  • COVID-19 diagnosis using AI
  • Vascular Anomalies and Treatments
  • Pneumocystis jirovecii pneumonia detection and treatment
  • COVID-19 diagnosis using AI
  • Air Quality and Health Impacts
  • Pneumocystis jirovecii pneumonia detection and treatment
  • Vascular Anomalies and Treatments
  • Air Quality and Health Impacts
  • Antifungal resistance and susceptibility
  • Long-Term Effects of COVID-19
  • Long-Term Effects of COVID-19
  • Antifungal resistance and susceptibility

Keywords (DOAJ)

  • airway inflammation
  • lung disease
  • occupational respiratory disease
  • pulmonary infection
  • thoracic oncology
  • immunology

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: